Headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned news articles about the medical research company an impact score of 45.8679710119224 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of PAREXEL International (NASDAQ:PRXL) traded down $0.02 during trading on Wednesday, hitting $88.08. The company had a trading volume of 7,021,100 shares, compared to its average volume of 1,041,144. PAREXEL International has a twelve month low of $51.16 and a twelve month high of $88.10. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 1.01.
ILLEGAL ACTIVITY WARNING: This news story was reported by BBNS and is the property of of BBNS. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://baseballnewssource.com/markets/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-parexel-international-prxl-share-price/1823194.html.
PAREXEL International Company Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.
Receive News & Ratings for PAREXEL International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International and related companies with our FREE daily email newsletter.